Impact on the Nitrogen Balance, Autonomy, Safety and Tolerance of Enteral Diets Made of With Nutrilon Without Lactose® Fortified by Concentration Versus by Maltodextrin and Oil Supplementation,After Surgery for Congenital Heart Disease, in Infants. (DIETCHIRCARD)
Controlled, Randomized, Double-blind, Monocentric Clinical Study Evaluating the Impact on the Nitrogen Balance, Autonomy, Safety and Tolerance of Enteral Diets Made of Nutrilon Without Lactose® Fortified by Concentration Versus by Maltodextrin and Oil Supplementation, After Surgery for Congenital Heart Disease, in Children Aged Zero to Two Years Old
Sponsor: Queen Fabiola Children's University Hospital
Terminated
Recuitment to slow
Other Congenital Heart Disease in Children trials with similar outcome
A NA clinical study on Congenital Heart Disease in Children, this trial is terminated or withdrawn. The trial is conducted by Queen Fabiola Children's University Hospital and has accumulated 7 data snapshots since 2017. Cardiovascular trials of this type often inform treatment guidelines for long-term patient management.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2021 — Jul 2024 [monthly]
Terminated NA
-
Jul 2020 — Jan 2021 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Aug 2018 — Jul 2020 [monthly]
Recruiting NA
▶ Show 2 earlier versions
-
Jun 2018 — Aug 2018 [monthly]
Recruiting NA
-
Jun 2017 — Jun 2018 [monthly]
Recruiting NA
First recorded
May 2017
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Queen Fabiola Children's University Hospital
For direct contact, visit the study record on ClinicalTrials.gov .